M. Agelidou

829 citations
26 papers · 661 indexed · h-index 12
Topics
Lung Cancer Research Studies (20 papers)Lung Cancer Treatments and Mutations (14 papers)Cancer therapeutics and mechanisms (10 papers)
Partner nations
GreeceKuwait

In The Last Decade

M. Agelidou

25 papers receiving 614 citations

Peers

M. Agelidou
Comparison fields: 5 of 50
  • Oncology 571
  • Pulmonary and Respiratory Medicine 430
  • Epidemiology 166
  • Molecular Biology 159
  • Cancer Research 51
Replace Xanthi Tsiafaki with:
Xanthi Tsiafaki Greece
Athina Agelidou Greece
Ph. Palamidas Greece
Carol A. Sherman United States
J. Boukovinas Greece
Enzo Veltri Italy
J.M. Sánchez-Torres Spain
Lucia Tixi Italy
Jung Shin Lee South Korea
M. Lomas Spain
M. Agelidou relative to Xanthi Tsiafaki Greece Xanthi Tsiafaki's profile →
Citations per field
00.5×4.3×
Xanthi Tsiafaki · 1×
Citations per year

Countries citing papers authored by M. Agelidou

Since Specialization
Citations

This map shows the geographic impact of M. Agelidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Agelidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Agelidou more than expected).

Fields of papers citing papers by M. Agelidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Agelidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Agelidou. The network helps show where M. Agelidou may publish in the future.

Co-authorship network of co-authors of M. Agelidou

This figure shows the co-authorship network connecting the top 25 collaborators of M. Agelidou. A scholar is included among the top collaborators of M. Agelidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Agelidou. M. Agelidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 11
4 90
5 33
6 42
7 24
8 2
9 38
10 5
11 6
12 7
13 5
14 38
15 13
16 16
17 14
18 108
19 2
20 65

About M. Agelidou

M. Agelidou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 26 papers that have together received 661 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (20 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Oncology (571 citations), Pulmonary and Respiratory Medicine (430 citations) and Epidemiology (166 citations). M. Agelidou has collaborated with scholars based in Greece and Kuwait. Frequent co-authors include Athina Agelidou, Pavlos Papakotoulas, Vassilis Georgoulias, Vassilis Georgoulias, Charalambos Kouroussis, E. Papadakis, S. Kakolyris, Αthanasios Kotsakis, Sofia Agelaki and Dora Hatzidaki. Their work appears in journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026